Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125322011 | 12532201 | 1 | I | 20160628 | 20160706 | 20160706 | EXP | GB-JNJFOC-20160627474 | JANSSEN | OMER O, COHEN P, NEONG SF, SMITH GV. PNEUMOCYSTIS PNEUMONIA COMPLICATING IMMUNOSUPPRESSIVE THERAPY IN CROHNS DISEASE: A PREVENTABLE PROBLEM ?. FRONTLINE GASTROENTEROL JUL-2016;7 (3):222 - 226. | 76.00 | YR | E | M | Y | 0.00000 | 20160706 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125322011 | 12532201 | 1 | PS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | U | UNKNOWN | 103772 | LYOPHILIZED POWDER |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125322011 | 12532201 | 1 | Crohn's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125322011 | 12532201 | OT |
| 125322011 | 12532201 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125322011 | 12532201 | Cytomegalovirus colitis | |
| 125322011 | 12532201 | Drug ineffective | |
| 125322011 | 12532201 | Pneumocystis jirovecii pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |